115 related articles for article (PubMed ID: 6734133)
1. Modern management of mixed bacterial infections.
Madhavan T
Compr Ther; 1984 Jun; 10(6):55-64. PubMed ID: 6734133
[No Abstract] [Full Text] [Related]
2. Aminoglycosides in combination in severe infections. Brussels, 31 May 1985.
J Antimicrob Chemother; 1986 Mar; 17 Suppl A():1-68. PubMed ID: 3710964
[No Abstract] [Full Text] [Related]
3. Management of bacterial infections in haematological patients.
Galea G
Br J Hosp Med; 1982 Jul; 28(1):74, 76, 79 passim. PubMed ID: 6289951
[No Abstract] [Full Text] [Related]
4. [Some advances in antibiotic treatment (author's transl)].
Reber H
Schweiz Rundsch Med Prax; 1981 Mar; 70(14):585-94. PubMed ID: 7243712
[No Abstract] [Full Text] [Related]
5. The aminoglycosides.
Tuazon C
Ear Nose Throat J; 1981 May; 60(5):233-8. PubMed ID: 7227273
[No Abstract] [Full Text] [Related]
6. [Necrotizing soft tissue infection].
Rath E; Shelef I; Avinoah E; Lichtman Y; Levy O; Atar D
Harefuah; 1998 May; 134(9):695-7, 750. PubMed ID: 10909616
[TBL] [Abstract][Full Text] [Related]
7. Current use for old antibacterial agents: polymyxins, rifampin, and aminoglycosides.
Kaye D
Infect Dis Clin North Am; 2004 Sep; 18(3):669-89, x. PubMed ID: 15308281
[TBL] [Abstract][Full Text] [Related]
8. [Tobramycin].
Nouv Presse Med; 1974 Apr; 3(0):38. PubMed ID: 4837112
[No Abstract] [Full Text] [Related]
9. Clinical assessment of newer antibiotics. Effect in compromised hosts and drug combinations.
Jackson GG
Scand J Infect Dis Suppl; 1980; Suppl 23():167-75. PubMed ID: 6937963
[No Abstract] [Full Text] [Related]
10. [Urinary tract infections in the involutive age. 2].
Migliori V; Londei M; Bonazzi A; Cavaciocchi P; Cuppini S
G Clin Med; 1981 Aug; 62(8):585-90. PubMed ID: 7308641
[No Abstract] [Full Text] [Related]
11. Present studies of therapy for anaerobic infections.
Finegold SM; Wexler HM
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S9-14. PubMed ID: 8953100
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic therapy in the management of infections in dental patients.
Gardner AF
Ann Dent; 1982; 41(1):7-22. PubMed ID: 6965042
[No Abstract] [Full Text] [Related]
13. Vibativ another weapon in the fight against antibiotic resistance.
Belavic JM
Nurse Pract; 2010 Aug; 35(8):7-9. PubMed ID: 20644442
[No Abstract] [Full Text] [Related]
14. [The treatment of bacterial infections with the newer antibiotics].
Schley G; Wenzel H
Med Klin; 1981 Mar; 76(7):200-7. PubMed ID: 6971983
[No Abstract] [Full Text] [Related]
15. [Modern trends in antibiotic therapy of difficult infections: amikacin sulfate. A meeting held in Naples with Professor Fernando De Ritis as Chairman].
Fabbrocini V
Minerva Med; 1980 Jan; 71(1):58-61. PubMed ID: 7354926
[No Abstract] [Full Text] [Related]
16. Comment on: Aminoglycoside drugs in clinical practice: an evidence-based approach.
Keuleyan EE; Kirilov KG
J Antimicrob Chemother; 2009 May; 63(5):1081-2; author reply 1082-3. PubMed ID: 19252182
[No Abstract] [Full Text] [Related]
17. Diabetic foot ulcer: assessment and management.
Deshpande MM
J Indian Med Assoc; 2008 Jun; 106(6):400. PubMed ID: 18839653
[No Abstract] [Full Text] [Related]
18. Cholangiosepsis: endoscopic drainage and antibiotic therapy.
Leung JW; Venezuela RR
Endoscopy; 1991 Jul; 23(4):220-3. PubMed ID: 1915139
[No Abstract] [Full Text] [Related]
19. [Which partner for the betalactam agent in empirical combined therapy? II. Aminoglycoside].
Mimoz O; Grollier G
Ann Fr Anesth Reanim; 2004 Jun; 23(6):639-42. PubMed ID: 15234735
[No Abstract] [Full Text] [Related]
20. New antimicrobials.
Davies AJ
Br J Hosp Med; 1982 Feb; 27(2):136-42. PubMed ID: 7059727
[No Abstract] [Full Text] [Related]
[Next] [New Search]